Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| USP14 Regulates DNA Damage Response and Is a Target for Radiosensitization in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2020 | 32887472 | PubTator, text mining | PubMed |
| Potential Doxorubicin-Mediated Dual-Targeting Chemotherapy in FANC/BRCA-Deficient Tumors via Modulation of Cellular Formaldehyde Concentration. | Chem Res Toxicol | 2020 | 32876438 | PubTator, text mining | PubMed |
| A Multiple Primary Malignancy Patient With FANCA Gene Mutation: A Case Report and Literature Review. | Front Oncol | 2020 | 32850347 | PubTator, text mining | PubMed |
| Role of DNA Methylation in the Resistance to Therapy in Solid Tumors. | Front Oncol | 2020 | 32850327 | PubTator, text mining | PubMed |
| Role of microRNA-7 in liver diseases: a comprehensive review of the mechanisms and therapeutic applications. | J Investig Med | 2020 | 32843369 | PubTator, text mining | PubMed |
| Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African Ancestry. | JCO Precis Oncol | 2020 | 32832836 | PubTator, text mining | PubMed |
| Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells. | Biomedicines | 2020 | 32825120 | PubTator, text mining | PubMed |
| Cytokines, JAK-STAT Signaling and Radiation-Induced DNA Repair in Solid Tumors: Novel Opportunities for Radiation Therapy. | Int J Biochem Cell Biol | 2020 | 32822847 | PubTator, text mining | PubMed |
| Polymorphism of XRCC3 in Egyptian Breast Cancer Patients. | Pharmgenomics Pers Med | 2020 | 32821150 | PubTator, text mining | PubMed |
| Persistent Hypoglycemia in Seven-year-old Saudi Child: A Case Report. | Oman Med J | 2020 | 32802414 | PubTator, text mining | PubMed |
| Novel FANCA mutation in the first fully-diagnosed patient with Fanconi anemia in Polish population - case report. | Mol Cytogenet | 2020 | 32793304 | PubTator, text mining | PubMed |
| A three-mRNA status risk score has greater predictive ability compared with a lncRNA-based risk score for predicting prognosis in patients with hepatocellular carcinoma. | Oncol Lett | 2020 | 32788937 | PubTator, text mining | PubMed |
| S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression. | Cells | 2020 | 32784836 | PubTator, text mining | PubMed |
| Evaluation of the upregulation and surface expression of hypoxanthine guanine phosphoribosyltransferase in acute lymphoblastic leukemia and Burkitt's B cell lymphoma. | Cancer Cell Int | 2020 | 32782434 | PubTator, text mining | PubMed |
| Acrylamide exposure represses neuronal differentiation, induces cell apoptosis and promotes tau hyperphosphorylation in hESC-derived 3D cerebral organoids. | Food Chem Toxicol | 2020 | 32763439 | PubTator, text mining | PubMed |
| Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer. | Cancer Sci | 2020 | 32761968 | PubTator, text mining | PubMed |
| Genetic dissection of spermatogenic arrest through exome analysis: clinical implications for the management of azoospermic men. | Genet Med | 2020 | 32741963 | PubTator, text mining | PubMed |
| MicroRNAs and Apoptosis in Colorectal Cancer. | Int J Mol Sci | 2020 | 32731413 | PubTator, text mining | PubMed |
| Identifying CpG methylation signature as a promising biomarker for recurrence and immunotherapy in non-small-cell lung carcinoma. | Aging (Albany NY) | 2020 | 32723974 | PubTator, text mining | PubMed |
| Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition. | Cell Death Dis | 2020 | 32719412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=34